Debate: Should statin be used in patients with heart failure?
AUTOR(ES)
Pietro Maggioni, Aldo
FONTE
BioMed Central
RESUMO
Statins reduce mortality of patients with coronary artery disease (CAD). However, by protocol, trials have excluded patients with chronic heart failure. Since the prevalent etiology of heart failure is CAD, preventing CAD may prevent heart failure progression. Statins may have other beneficial effects besides cholesterol lowering, such as anti-inflammatory properties and improvement of endothelial function. On the contrary, high levels of cholesterol can be beneficial in heart failure patients on the basis of the ability of serum lipoproteins to modulate inflammatory response. Furthermore, statins affecting mitochondrial function can have a deleterious effect on skeletal or cardiac muscles. Despite all these conflicting data, there is no evidence from trials on the effects of statins in patients with heart failure. For this reason, the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) investigators planned a controlled trial testing the effect of statins in patients with heart failure of different etiology.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=64827Documentos Relacionados
- Debate: Statins should be used in patients with heart failure
- Pro/con clinical debate: Hydroxyethylstarches should be avoided in septic patients
- Pro/con clinical debate: Is high-frequency oscillatory ventilation useful in the management of adult patients with respiratory failure?
- Debate: Albumin administration should not be avoided
- Is aspirin safe for patients with heart failure?
